Lv7
4220 积分 2022-07-07 加入
Lung Transplant for Refractory Lung-Limited Stage IV Non–Small Cell Lung Cancer
14小时前
已完结
Cancer burden and control in China: landscape, trends and challenges
13天前
已完结
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
18天前
已完结
PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
1个月前
已关闭
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
1个月前
已完结
PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
2个月前
已完结
Ovarian cancer
2个月前
已关闭
皖公网安备34019202002308
